HPC (hematopoietic progenitor cells)

N/A

Report date: 2024/01/25 10:49:12

Base Information

Drug NameHPC (hematopoietic progenitor cells)
Drug Alias Name造血祖细胞 (hematopoietic progenitor cells)脐带血造血祖细胞 (hematopoietic progenitor cells)
ClassificationBiologics > Blood componentsCell and gene therapy > Cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsHematopoietic stem cell transplantation (HSCT)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/05/24
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesClinimmune Labs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeB05AX04
Related LinksN/A